
More Americans believe in the effectiveness of vaccines developed to protect newborns and seniors against respiratory syncytial virus (RSV). More than half of U.S. adults (52%) think the RSV vaccine given to pregnant women will protect newborns from the infection, up from 42% a year ago, say survey results from the Annenberg Public Policy Center… read on > read on >